Inventor · Montpellier, FR

Andre Pelegrin

14Patents
3h-index
32Co-inventors
60Inventor score

Filing activity: Mar 23, 1994 → Apr 28, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US9169316B2 Production of antibody formats and immunological applications of said formats Chemistry; Metallurgy 23 Active
US5672513A Carcino-embryonic antigen derivatives lacking the carboxyl terminal end Emerging Cross-Sectional Technologies 4 Expired
US10385137B2 Production of antibody formats and immunological applications of said formats Chemistry; Metallurgy 4 Active
US9127065B2 Anti-human HER3 antibodies and uses thereof Chemistry; Metallurgy 3 Active
US9458239B2 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II) Physics 2 Active
US8278423B2 Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) Physics 2 Active
US9249228B2 Anti-Axl antibodies and uses thereof Chemistry; Metallurgy 1 Active
US9409988B2 Anti-Axl antibodies and uses thereof Chemistry; Metallurgy 1 Active
US11001634B2 Anti-human-HER3 antibodies and uses thereof Chemistry; Metallurgy 0 Active
US9346883B2 Antibodies against HER3 Chemistry; Metallurgy 0 Active
US12054550B2 Bispecific antibodies targeting EGFR and HER2 Chemistry; Metallurgy 0 Active
US7892542B2 Human anti-idiotypic antibody fragments that mimic HER-2/neu Chemistry; Metallurgy 0 Active
US10196455B2 Neuregulin allosteric anti-HER3 antibody Chemistry; Metallurgy 0 Active
US9522956B2 Combination therapy using anti-EGFR and anti-HER2 antibodies Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.